Kura Oncology Inc (KURA)
21.01
+0.38
(+1.84%)
USD |
NASDAQ |
May 06, 16:00
21.02
+0.02
(+0.07%)
After-Hours: 20:00
Kura Oncology Price to Book Value: 3.169 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 3.169 |
| May 03, 2024 | 3.112 |
| May 02, 2024 | 3.106 |
| May 01, 2024 | 3.059 |
| April 30, 2024 | 2.959 |
| April 29, 2024 | 3.026 |
| April 26, 2024 | 2.964 |
| April 25, 2024 | 2.866 |
| April 24, 2024 | 2.828 |
| April 23, 2024 | 2.825 |
| April 22, 2024 | 2.744 |
| April 19, 2024 | 2.644 |
| April 18, 2024 | 2.667 |
| April 17, 2024 | 2.713 |
| April 16, 2024 | 2.804 |
| April 15, 2024 | 2.867 |
| April 12, 2024 | 2.938 |
| April 11, 2024 | 3.077 |
| April 10, 2024 | 3.002 |
| April 09, 2024 | 3.119 |
| April 08, 2024 | 3.080 |
| April 05, 2024 | 3.071 |
| April 04, 2024 | 3.071 |
| April 03, 2024 | 3.068 |
| April 02, 2024 | 3.095 |
| Date | Value |
|---|---|
| April 01, 2024 | 3.291 |
| March 28, 2024 | 4.088 |
| March 27, 2024 | 4.057 |
| March 26, 2024 | 3.914 |
| March 25, 2024 | 4.023 |
| March 22, 2024 | 4.101 |
| March 21, 2024 | 4.092 |
| March 20, 2024 | 4.205 |
| March 19, 2024 | 4.157 |
| March 18, 2024 | 4.032 |
| March 15, 2024 | 4.281 |
| March 14, 2024 | 4.212 |
| March 13, 2024 | 4.375 |
| March 12, 2024 | 4.276 |
| March 11, 2024 | 4.373 |
| March 08, 2024 | 4.510 |
| March 07, 2024 | 4.266 |
| March 06, 2024 | 4.350 |
| March 05, 2024 | 4.032 |
| March 04, 2024 | 4.084 |
| March 01, 2024 | 4.138 |
| February 29, 2024 | 4.04 |
| February 28, 2024 | 4.098 |
| February 27, 2024 | 4.170 |
| February 26, 2024 | 3.975 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.309
Minimum
Oct 23 2023
8.967
Maximum
Dec 11 2020
2.848
Average
2.458
Median
Jul 20 2022
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.196 |
| Perspective Therapeutics Inc | 14.29 |
| Protalix BioTherapeutics Inc | 2.416 |
| Electromed Inc | 3.776 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 21.01 |
| Earnings Yield | -10.33% |
| Market Cap | 1.601B |